Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1975 1
1983 1
1989 1
1992 2
1993 1
1994 1
1995 4
1996 1
1997 2
2002 2
2003 2
2004 2
2005 6
2006 4
2007 6
2008 7
2009 2
2010 5
2011 4
2012 4
2013 8
2014 4
2015 2
2016 7
2017 8
2018 4
2019 5
2020 8
2021 9
2022 9
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Patient-Derived Cancer Models.
Di Renzo MF, Corso S. Di Renzo MF, et al. Among authors: corso s. Cancers (Basel). 2020 Dec 15;12(12):3779. doi: 10.3390/cancers12123779. Cancers (Basel). 2020. PMID: 33333972 Free PMC article.
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Petrelli A, Rizzolio S, Pietrantonio F, Bellomo SE, Benelli M, De Cecco L, Romagnoli D, Berrino E, Orrù C, Ribisi S, Moya-Rull D, Migliore C, Conticelli D, Maina IM, Puliga E, Serra V, Pellegrino B, Llop-Guevara A, Musolino A, Siena S, Sartore-Bianchi A, Prisciandaro M, Morano F, Antista M, Fumagalli U, De Manzoni G, Degiuli M, Baiocchi GL, Amisano MF, Ferrero A, Marchiò C, Corso S, Giordano S. Petrelli A, et al. Among authors: corso s. Cancer Res. 2023 May 15;83(10):1699-1710. doi: 10.1158/0008-5472.CAN-22-2620. Cancer Res. 2023. PMID: 37129948 Free PMC article.
Upper limbs: how physically limited is your patient?
Furlanetto KC, Correia NS, Corso SD. Furlanetto KC, et al. Among authors: corso sd. J Bras Pneumol. 2020 Mar 2;46(1):e20190430. doi: 10.1590/1806-3713/e20190430. J Bras Pneumol. 2020. PMID: 32130348 Free PMC article. No abstract available.
Molecularly Targeted Therapies for Gastric Cancer. State of the Art.
Reddavid R, Dagatti S, Franco C, Puca L, Tomatis M, Corso S, Giordano S, Degiuli M. Reddavid R, et al. Among authors: corso s. Cancers (Basel). 2021 Aug 14;13(16):4094. doi: 10.3390/cancers13164094. Cancers (Basel). 2021. PMID: 34439248 Free PMC article. Review.
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial.
Pietrantonio F, Manca P, Bellomo SE, Corso S, Raimondi A, Berrino E, Morano F, Migliore C, Niger M, Castagnoli L, Pupa SM, Marchiò C, Di Bartolomeo M, Restuccia E, Lambertini C, Tabernero J, Giordano S. Pietrantonio F, et al. Among authors: corso s. Clin Cancer Res. 2023 Feb 1;29(3):571-580. doi: 10.1158/1078-0432.CCR-22-2533. Clin Cancer Res. 2023. PMID: 36413222 Free PMC article.
Cancer therapy: can the challenge be MET?
Corso S, Comoglio PM, Giordano S. Corso S, et al. Trends Mol Med. 2005 Jun;11(6):284-92. doi: 10.1016/j.molmed.2005.04.005. Trends Mol Med. 2005. PMID: 15949770 Review.
Personalized therapeutic strategies in HER2-driven gastric cancer.
Ughetto S, Migliore C, Pietrantonio F, Apicella M, Petrelli A, D'Errico L, Durando S, Moya-Rull D, Bellomo SE, Rizzolio S, Capelôa T, Ribisi S, Degiuli M, Reddavid R, Rapa I, Fumagalli U, De Pascale S, Ribero D, Baronchelli C, Sgroi G, Rausa E, Baiocchi GL, Molfino S, Manenti S, Bencivenga M, Sacco M, Castelli C, Siena S, Sartore-Bianchi A, Tosi F, Morano F, Raimondi A, Prisciandaro M, Gloghini A, Marsoni S, Sottile A, Sarotto I, Sapino A, Marchiò C, Cassoni P, Guarrera S, Corso S, Giordano S. Ughetto S, et al. Among authors: corso s. Gastric Cancer. 2021 Jul;24(4):897-912. doi: 10.1007/s10120-021-01165-w. Epub 2021 Mar 23. Gastric Cancer. 2021. PMID: 33755862 Free article.
123 results